Novel Life Science Reagents
| Product Name | CAS No. | Specification | Application | Registration |
| Emtricitabine (BW1592) | 143491-57-0 | 98+% | ||
| Everolimus (RAD001） | 159351-69-6 | 98+% | ||
| Ixabepilone | 219989-84-1 | 98+% | Microtubule Associated inhibitor | |
| Epirubicin Hydrochloride (Epirubicin HCl) | 56390-09-1 | 98+% | Topoisomerase inhibitor | Apoptosis related activator | |
| Daunorubicin Hydrochloride | 23541-50-6 | 99+% | Antineoplastic Agents | Antineoplastic and Immunosuppressive Antibiotics inhibitor | Topoisomerase inhibitor | ADC Cytotoxin | COVID-19 inhibitor | DNA/RNA Synthesis inhibitor | Apoptosis related activator | |
| Idarubicin Hydrochloride （Idarubicin HCl） | 57852-57-0 | 98+% | Topoisomerase inhibitor | Antibiotics inhibitor | Autophagy activator | |
| Lamivudine (3TC) | 134678-17-4 | 98+% | ||
| Fluocinolone Acetonide | 67-73-2 | 98+% | ||
| Fidaxomicin (Lipiarmycin) | 873857-62-6 | 98+% | ||
| L-Biopterin (6-Biopterin) | 22150-76-1 | 98+% | ||
| Bumetanide | 28395-03-1 | 98+% | ||
| Nintedanib (BIBF 1120) | 656247-17-5 | 98+% | VEGFR inhibitor | FGFR inhibitor| PDGFR inhibitor | Src inhibitor | |
| Cidofovir Anhydrous | 113852-37-2 | 98+% | ||
| Abiraterone (CB-7598) | 154229-19-3 | 99+% |
Products
- All
- Pharmaceutical Intermediates
- Active Pharmaceutical Ingredients
- Drug Impurities & Metabolites
- Novel Life Science Reagents
- Signaling Pathways
- Inhibitory Antibodies
- Bioactive Small Molecules
- Screening Compounds
- Stable Isotope Labelled Compounds
- COVID-19 Related Inhibitors
- Amino Acids & Vitamins
- Natural Products
- Health & Nutritional Ingredients
- Pharmaceutical Excipients
- Specialty Chemicals & Building Blocks
Custom Synthesis-High Value-Added Advanced Pharmaceutical Intermediates
E-Mail: sales (at)Chemleader.com.cn
E-Mail: sales (at)Chemleader.com.cn